2,987
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Socioeconomic circumstances and incidence of chronic obstructive pulmonary disease (COPD) in an urban population in Sweden

, , &
Pages 51-57 | Received 17 Oct 2018, Accepted 09 Feb 2019, Published online: 27 Mar 2019

References

  • Calverley PM, Walker P. Chronic obstructive pulmonary disease. Lancet (London, England). 2003;362(9389):1053–1061. doi: 10.1016/S0140-6736(03)14416-9.
  • Barnes PJ. Chronic obstructive pulmonary disease: a growing but neglected global epidemic. PLoS Med. 2007;4(5):e112. doi: 10.1371/journal.pmed.0040112.
  • Buist AS, Vollmer WM, McBurnie MA. Worldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiative. Int J Tuberc Lung Dis. 2008;12(7):703–708.
  • Mathers CD, Loncar D, Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. doi: 10.1371/journal.pmed.0030442.
  • Inghammar M, Engstrom G, Lofdahl CG, Egesten A. Validation of a COPD diagnosis from the Swedish Inpatient Registry. Scand J Public Health. 2012;40(8):773–776. doi: 10.1177/1403494812463172.
  • Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet (London, England). 2007;370(9589):765–773. doi: 10.1016/S0140-6736(07)61380-4.
  • Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax 2006;61(11):935–939. doi: 10.1136/thx.2006.062802.
  • Hemminki K, Li X, Sundquist K. Familial risks for chronic obstructive pulmonary disease among siblings based on hospitalisations in Sweden. J Epidemiol Commun Health. 2008;62(5):398–402. doi: 10.1136/jech.2007.063156.
  • MacNee W. Accelerated lung aging: a novel pathogenic mechanism of chronic obstructive pulmonary disease (COPD). Biochem Soc Trans. 2009;37(Pt 4):819–823. doi: 10.1042/BST0370819.
  • Anto JM, Vermeire P, Vestbo J, Sunyer J. Epidemiology of chronic obstructive pulmonary disease. Eur Respir J. 2001;17(5):982–994.
  • Eisner MD, Blanc PD, Omachi TA, Yelin EH, Sidney S, Katz PP, Ackerson LM, Sanchez G, Tolstykh I, Iribarren C. Socioeconomic status, race and COPD health outcomes. J Epidemiol Commun Health. 2011;65(1):26–34. doi: 10.1136/jech.2009.089722.
  • Danielsson P, Olafsdottir IS, Benediktsdottir B, Gislason T, Janson C. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden – the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study. Clin Respir J. 2012;6(2):120–127. doi: 10.1111/j.1752-699X.2011.00257.x.
  • Miravitlles M, Naberan K, Cantoni J, Azpeitia A. Socioeconomic status and health-related quality of life of patients with chronic obstructive pulmonary disease. Respiration. 2011;82(5):402–408. doi: 10.1159/000328766.
  • Prescott E, Vestbo J. Socioeconomic status and chronic obstructive pulmonary disease. Thorax. 1999;54(8):737–741.
  • Kanervisto M, Vasankari T, Laitinen T, Heliovaara M, Jousilahti P, Saarelainen S. Low socioeconomic status is associated with chronic obstructive airway diseases. Respir Med. 2011;105(8):1140–1146. doi: 10.1016/j.rmed.2011.03.008.
  • Prescott E, Lange P, Vestbo J. Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study. Eur Respir J. 1999;13(5):1109–1114.
  • Sweden Population and Housing Census 1990. Statistics Sweden; 1992.
  • Engstrom G, Segelstorm N, Ekberg-Aronsson M, Nilsson PM, Lindgarde F, Lofdahl CG. Plasma markers of inflammation and incidence of hospitalisations for COPD: results from a population-based cohort study. Thorax 2009;64(3):211–215. doi: 10.1136/thx.2008.102079.
  • Berglund G, Eriksson KF, Israelsson B, Kjellstrom T, Lindgarde F, Mattiasson I, Nilsson JA, Stavenow L. Cardiovascular risk groups and mortality in an urban swedish male population: the Malmo Preventive Project. J Intern Med. 1996;239(6):489–497. doi: 10.1046/j.1365-2796.1996.483819000.x.
  • Berglund G, Nilsson P, Eriksson KF, Nilsson JA, Hedblad B, Kristenson H, Lindgarde F. Long-term outcome of the Malmo preventive project: mortality and cardiovascular morbidity. J Intern Med. 2000;247(1):19–29. doi: 10.1046/j.1365-2796.2000.00568.x.
  • Engstrom G, Hedblad B, Rosvall M, Janzon L, Lindgarde F. Occupation, marital status, and low-grade inflammation: mutual confounding or independent cardiovascular risk factors? Arterioscler Thromb Vasc Biol. 2006;26(3):643–648. doi: 10.1161/01.ATV.0000200100.14612.bb.
  • Ricci F, Wollmer P, Engström G, et al. Markers of cardiovascular autonomic dysfunction predict COPD in middle-aged subjects. Eur Respir J 2018;51:1702481 [https://doi.org/10.1183/13993003.02481-2017]
  • Disano J, Goulet J, Muhajarine N, Neudorf C, Harvey J. Social-economic status and rates of hospital admission for chronic disease in urban Canada. Can Nurse. 2010;106(1):24–29.
  • Antonelli-Incalzi R, Ancona C, Forastiere F, Belleudi V, Corsonello A, Perucci CA. Socioeconomic status and hospitalization in the very old: a retrospective study. BMC public health. 2007;7:227.
  • Chen Y, Breithaupt K, Muhajarine N. Occurrence of chronic obstructive pulmonary disease among Canadians and sex-related risk factors. J Clin Epidemiol. 2000;53(7):755–761. doi: 10.1016/S0895-4356(99)00211-5.
  • Erickson SE, Iribarren C, Tolstykh IV, Blanc PD, Eisner MD. EFfect of race on asthma management and outcomes in a large, integrated managed care organization. Arch Intern Med. 2007;167(17):1846–1852. doi: 10.1001/archinte.167.17.1846.
  • Kauffmann F, Drouet D, Lellouch J, Brille D. Twelve years spirometric changes among Paris area workers. Int J Epidemiol. 1979;8(3):201–212. doi: 10.1093/ije/8.3.201.
  • Hajat A, Hsia C, O'Neill MS. Socioeconomic disparities and air pollution exposure: a global review. Curr Environ Health Rep. 2015;2(4):440–450. doi: 10.1007/s40572-015-0069-5.
  • Hiscock R, Bauld L, Amos A, Fidler JA, Munafo M. Socioeconomic status and smoking: a review. Ann N Y Acad Sci. 2012;1248:107–123. doi: 10.1111/j.1749-6632.2011.06202.x.
  • Osler M, Prescott E. Psychosocial, behavioural, and health determinants of successful smoking cessation: a longitudinal study of Danish adults. Tob Control. 1998;7(3):262–267. doi: 10.1136/tc.7.3.262.
  • Sterling T, Weinkam J. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies. Soc Sci Med. 1990;30(4):457–467.
  • Lindberg A, Bjerg-Backlund A, Ronmark E, Larsson LG, Lundback B. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking. Respir Med. 2006;100(2):264–272. doi: 10.1016/j.rmed.2005.04.029.
  • Midlov P, Calling S, Sundquist J, Sundquist K, Johansson SE. The longitudinal age and birth cohort trends of smoking in Sweden: a 24-year follow-up study. Int J Public Health. 2014;59(2):243–250. doi: 10.1007/s00038-013-0535-5.
  • Zhong Y, Rosengren A, Fu M, Welin L, Welin C, Caidahl K, Mandalenakis Z, Dellborg M, Svärdsudd K, Hansson PO. Secular changes in cardiovascular risk factors in Swedish 50-year-old men over a 50-year period: the study of men born in 1913, 1923, 1933, 1943, 1953 and 1963. Eur J Prev Cardiol. 2017;24(6):612–620. doi: 10.1177/2047487316676905.
  • Wilhelmsen L, Welin L, Svärdsudd K, Wedel H, Eriksson H, Hansson PO, Rosengren A. Secular changes in cardiovascular risk factors and attack rate of myocardial infarction among men aged 50 in Gothenburg, Sweden. Accurate prediction using risk models. J Intern Med. 2008;263(6):636–643. doi: 10.1111/j.1365-2796.2008.01931.x.